Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Poster Print Size: This poster template is 44” high by 44” wide. It can be used to print any poster with a 1:1 aspect ratio.
Placeholders: The various elements included in this poster are ones we often see in medical, research, and scientific posters. Feel free to edit, move, add, and delete items, or change the layout to suit your needs. Always check with your conference organizer for specific requirements.
Image Quality: You can place digital photos or logo art in your poster file by selecting the Insert, Picture command, or by using standard copy & paste. For best results, all graphic elements should be at least 150-200 pixels per inch in their final printed size. For instance, a 1600 x 1200 pixel photo will usually look fine up to 8“-10” wide on your printed poster.
To preview the print quality of images, select a magnification of 100% when previewing your poster. This will give you a good idea of what it will look like in print. If you are laying out a large poster and using half-scale dimensions, be sure to preview your graphics at 200% to see them at their final printed size.
Please note that graphics from websites (such as the logo on your hospital's or university's home page) will only be 72dpi and not suitable for printing.
[This sidebar area does not print.]
Change Color Theme: This template is designed to use the built-in color themes in the newer versions of PowerPoint.
To change the color theme, select the Design tab, then select the Colors drop-down list.
The default color theme for this template is “Office”, so you can always return to that after trying some of the alternatives.
Printing Your Poster: Once your poster file is ready, visit www.genigraphics.com to order a high-quality, affordable poster print. Every order receives a free design review and we can deliver as fast as next business day within the US and Canada.
Genigraphics® has been producing output from PowerPoint® longer than anyone in the industry; dating back to when we helped Microsoft® design the PowerPoint® software.
US and Canada: 1-800-790-4001
Email: [email protected]
[This sidebar area does not print.]
1. EIT involves oxidative stress and lipid peroxidation early on after the
implantation.
2. L-NAC, Mannitol and Dex are effective alone in protecting the
sensory cells in vitro at high doses.
3. A cocktail containing L-NAC, Mannitol and Dex at much lower doses
of each compound, is effective in protecting sensory cells.
4. The three compounds can be combined with a synergistic effect
allowing a decrease in the potential side effects of each of the
compound.
Otoprotection by a Combination of L-NAC, Mannitol and Dex in an In Vitro Model of Cochlear Implant Trauma
Adrien A Eshraghi, MD; Jeenu Mittal, MSc; Jonathan Roell, BS; Mateo Guardiola, MS; Fred F Telischi, MD;
Dustin Lang, MS; Thomas R Van De Water, PhD; Esperanza Bas, PhD; Chhavi Gupta, PhD; Helio Rodrigues, MD
University of Miami Hearing Research Laboratory, Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, USA,
Adrien A Eshraghi MD, MSc, FACS
Professor of Otolaryngology and Biomedical Engineering
Director, Hearing Research Laboratory
Co-Director, University of Miami Ear Institute
University of Miami Miller School of Medicine
Email: [email protected], Phone::304-243-1484
1. Eshraghi AA, et al. (2005). Pattern of hearing loss in a rat model of cochlear implantation trauma. Otol Neurotol. 26: 442-7.
2. Eshraghi AA, et al. (2013). Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-Jun-N-terminal kinase signaling. Laryngoscope. 123:S1-14.
3. Bas E et al. (2012). Mannitol protects hair cells against tumor necrosis factor α-induced loss. Otol Neurotol. 33(9): 1656-1663.
4. Feghali JG et al. (2001). L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope. 111: 1147-1155.
5. Kopke RD et al. Am J Otol (1997) Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. 18(5):559-71.
6. Eshraghi AA, et al. (2007) Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol. 28(6):842-9
7. Hamernik RP, et al. (2008). The effectiveness of N-acetyl-L-cysteine (L-NAC) in the prevention of severe noise-induced hearing loss. Hear Res 239:99–106.
Materials and Methods
1. The EIT resulted in an increased production of the total reactive
oxygen species (ROS) in both the HCs and the supporting cells
(SCs).
2. There was an increase of total hair cell (THC) loss in the EIT OC
explants when compared with control group HC counts or the tri-
therapy cochlea.
3. We defined the dosage of L-NAC, Mannitol and Dex for the
survival of 50% protection of hair cells in vitro. Their combination
provided close to 96% protection demonstrating a synergistic
effect.
4. This combination therapy may be beneficial in other type of inner
ear trauma that can result in hair cell loss.
Results/Discussion
Conclusion
Results:FITC-phalloidin staining of HCs & HC counts
The pattern of hearing loss post cochlear electrode
implant insertion trauma (EIT) is described as an acute
loss of hearing followed by the gradual loss of residual
hearing on the days following the implantation.(1) This
inner ear trauma initiates multiple molecular
mechanisms such as oxidative stress, JNK activation
and caspase-3 activation in hair cells (HCs) or support
cells (SCs) resulting in initiation of programmed cell
death within the damaged tissues of the cochlea which
leads to loss of residual hearing.(2) In earlier studies L-
N-acetylcysteine (L-NAC) (an antioxidant), Mannitol
(osmotic and diuretic effects) and dexamethasone
(Dex) (a steroid) have been shown independently to
protect the HCs loss against different types of inner ear
trauma.(3-7) These 3 molecules have different types of
otoprotective properties that might have synergistic
effects.
Molecular mechanisms involved in EIT (2)
Background
References Contact Information
Objectives
To test the otoprotective effects of the tri-therapy (L-
NAC + Mannitol + Dex) in an in vitro model of inner ear
trauma (e.g. cochlear implantation trauma).
Supported by research grant from MED-EL Corporation, Innsbruck, Austria to Dr. Adrien A Eshraghi, MD, FACS
BloodVe
ssel
TNFR1
TNF
CellM
embra
ne
Nucleus
Trauma
Chemokines
Oxida veStress
MembraneDamage
Ca2+
Ca2+
ApoptosisAAE&DML2012
Caspase-8
Caspase-3
↑Bax:Bcl2ra o
MAPK/JNK
p-JNK
CytCApoptosome
C-Jun
p-c-Jun
↑Baxtranscrip on
GCR
DXM
More
Inflam
maon
An oxidants
NFκBsignaling
D-JNKI-1
MitochondrialSupport
The organ of Corti from control explants shows three well organized
rows of outer hair cells (OHCs) and a single row of inner hair cells
(IHCs), while the organ of Corti having EIT shows areas of damaged
OHC and IHCs with missing hair cells or damaged stereocilia. The
explants exposed to EIT and treated with L-NAC (5mM) + Mannitol
(100mM) + Dex (20 μg/mL) shows the same pattern of preservation
of OHC and IHCs organization as seen in control explants. The
graph show the percentage of living OHCs in each group .
Cochlea explants were dissected from P-3 rats and
placed in serum-free media. Explants were divided into
multiple groups:
1. Control groups (6 explants per group; a total of 12
explants):
1. Control (no trauma, no drug)
2. EIT (implant trauma , no drug)
2. Ten experimental groups (6 explants per group; a total
of 60 explants):
1. EIT + L-NAC (5, 2 or 1 mM)
2. EIT + Mannitol (100, 50 or 10 mM)
3. EIT + Dex (20, 10 or 5 µg/mL)
4. EIT +L-NAC + Mannitol + Dex
In the EIT groups, a 0.28-mm diameter monofilament
fishing line was introduced through the small
cochleostomy located next to the round window area,
allowing for an insertion of between 110 and 150
degrees. Oxidative stress was studied in all explants
post this EIT.
After EIT was caused, explants were cultured in media
containing L-NAC alone, Mannitol alone or Dex alone at
decreasing concentrations.
Concentrations of L-NAC, Mannitol and Dex that showed
50 percent protection of hair cell loss individually were
used as a combination in the experimental group 4.
.
• For EIT in the 3-day-old (P-3) rat cochlea,
a 0.28-mm diameter monofilament fishing
line was introduced through the small
cochleostomy located next to the round
window area, allowing for an insertion of
between 110 and 150 degrees. (3) • After EIT was caused, explants were
cultured in media containing the single
therapeutic compound (L-NAC, Mannitol,
and Dex) at varying concentrations as well
as the cocktail containing all three.
CellROX™ labeling is seen in the middle and basal turns of the
EIT exposed specimens in both HCs and SCs, but is absent in the
control and EIT + L-NAC + Mannitol + Dex specimens. The graph
shows the mean signal intensity of CellROX™ labeling (n = 9
samples) in the HCs and SCs for each group (control, EIT, and EIT
+L-NAC + Dex + Mannitol).
Result: Immunostaining for ROS (CellROX)
EIT procedure for the 3-day-old (P-3) rat cochlea
Surface preparations of HCs and SCs stained with anti-HNE (red)
and DAPI (blue) of the middle and basal turns from each group
(control, EIT, and EIT + L-NAC + Mannitol + Dex) are
represented. Anti-HNE labeling is seen in the basal turn of the
EIT exposed specimens but is absent in the control and EIT+ L-
NAC + Mannitol + Dex specimens. The graphs shows the mean
signal intensity of anti-HNE labeling (n=9 samples) in the HCs
and SCs for each group (control, EIT, and EIT + L-NAC + Mannitol + Dex).
Result: Immunostaining for membrane damage (HNE)
Results: FITC-phalloidin staining of HCs
While the lower concentrations of L-NAC
(2mM), Mannitol (10mM) and Dex
(5µg/ml) showed only partial protection
against HCs loss, the cocktail containing
those same concentrations combined
showed a total protection against HCs
loss.